Consumer Healthcare: Hims & Hers grew revenue 49%, but gross margin fell from 74% to 57% and full-year adjusted EBITDA guidance was lowered. Shares fell 16.61%, highlighting scrutiny of revenue conversion into profit

$HIMS

$HIMSB

$HIMS.US